Eckert & Ziegler Stock Forum

Analyst updates, 05.11.

⬆️⬆️⬆️

- ODDO BHF raises the price target for BIONTECH from USD 110 to USD 130. Outperform. $BNTX (+3.76%)

- BARCLAYS raises the price target for AIRBUS from EUR 161 to EUR 165. Overweight. $AIR (-1.42%)

- CITIGROUP raises the price target for SCOUT24 from EUR 91 to EUR 94.50. Buy. $G24 (+0.84%)

- WARBURG RESEARCH raises the price target for REDCARE PHARMACY from EUR 174 to EUR 176. Buy. $RDC (+9.53%)

- DEUTSCHE BANK RESEARCH raises the price target for RYANAIR from EUR 17 to EUR 17.50. Hold. $RYA (+0.25%)

- BERNSTEIN rates EBAY from Market-Perform to Outperform. Target price USD 70. $EBAY (+0.56%)

- ODDO BHF raises the price target for SALZGITTER from EUR 14 to EUR 15.50. Underperform. $SZG (+2.23%)

- BARCLAYS raises the target price for COMMERZBANK from EUR 16 to EUR 17. Equal-Weight. $CBK (-1.43%)

- BARCLAYS raises the target price for MTU from EUR 295 to EUR 340. Equal-Weight. $MTX (-0.88%)

- MORGAN STANLEY rates LUFTHANSA to Equal-Weight. Target price EUR 7. $LHA (+0.59%)

- BERENBERG raises the price target for DEUTSCHE KONSUM REIT from EUR 3.50 to EUR 5. Hold.

⬇️⬇️⬇️

- GOLDMAN lowers the price target for MERCEDES-BENZ from EUR 65 to EUR 63. Buy. $MBG (-3.33%)

- UBS lowers target price for 1&1 from EUR 21.60 to EUR 21. Buy.

- WARBURG RESEARCH lowers the price target for GFT TECHNOLOGIES from EUR 40 to EUR 37.50. Buy. $GFT (-0.78%)

- HAUCK AUFHÄUSER IB lowers the price target for ECKERT & ZIEGLER from EUR 63.50 to EUR 55. Buy. $EUZ (+0.1%)

- BARCLAYS lowers the price target for BNP PARIBAS from EUR 90 to EUR 85. Overweight. $BNP (+0.1%)

- BERENBERG downgrades SCHNEIDER ELECTRIC from Buy to Hold and lowers price target from EUR 261 to EUR 255. $SU (-0.48%)

- BERENBERG lowers the price target for BEFESA from EUR 41 to EUR 31. Buy. $BFSA (-2.8%)

Hey, why does $EUZ (+0.1%) part of information technology? It's actually pharma, isn't it? @Kundenservice

$PTP (-1.84%) Pentixapharm,

What exactly is the company that was spun off from Eckert and Ziegler? $EUZ (+0.1%) was spun off?

Andreas Eckert - founder of Eckert on this:

4 active ingredients including 2 in phase III and 2 in I/IIa

Target 2027 to bring both phase III diagnostics to market with EUR 55m expenditure.

However, further financing measures are required here.

20.8 million shares + 3.9 million in free float.

Other competitors in the market are

Telix Pharma and $TLX (-0.51%)

Lantheus Holding $LNTH (-0.29%)

Is the spin-off implemented automatically or do I have to book the new securities myself? $EUZ (+0.1%)

Pentixapharm is planning its IPO for October 2024, the first of a biotech company in Germany for eight years.

The company aims to raise up to 23,4 million euros by raising up to 3,9 million new shares at a price of 4,70 to 6,00 Euro will be offered.

The subscription period began on September 24, with the stock market debut on 3. October.

Pentixapharm develops radiopharmaceuticals for diagnosis and therapy of a variety of diseases, especially cancer cancers and inflammatory diseases.

If the placement is completed, a market capitalization of 132,7 million euros is targeted.

In addition, a convertible bond of up to EUR 18.5 million is expected from the parent company Eckert & Ziegler $EUZ (+0.1%) which does not wish to continue financing the clinical development of Pentixapharm.

Who of you is invested in $EUZ (+0.1%) and what do you think of the IPO of Pentixapharm?

Are you selling after the IPO or are you holding on to both companies?

$EUZ (+0.1%) Pentixapharm produces radioisotopes for medical applications, etc.

Pentixapharm, on the other hand, concentrates on the production of radiopharmaceuticals for the diagnosis and treatment of diseases, particularly cancer.

I personally find both companies interesting and will continue to hold both.

Clean breakout under high volume at $EUZ (+0.1%)

I am curious to see if $EUZ (+0.1%) will finally rise sustainably again.🚀

What do you think of $EUZ (+0.1%) shares?

I've been reading up on the share a bit over the last few days and will probably build up a small position in the near future.

(Thanks in advance for your answers!)

If you don't know the share yet, I think you can get a good little insight here:

http://www.aktien-baron.de/2024/05/eckert-ziegler-strahlende-zukunft-oder_16.html

Eckert & Ziegler
$EUZ (+0.1%) significant year-on-year increase in sales and earnings in Q1. Forecast for 2024 confirmed.

1st quarter 2024:

Sales EUR 67.6 million (previous year: EUR 57.9 million)

EBIT before special items EUR 15.0 million (previous year: EUR 10.7 million)

Net profit EUR 8.5 million (previous year: EUR 4.7 million)

Forecast for 2024:

Sales of just under EUR 265 million (confirmed)

EBIT before special items of around EUR 50 million (confirmed)

What is the share price doing? It's finally going up again and has jumped 12% today.

I like it 🤑🤞🏼

$EUZ (+0.1%) What's going on here today? Can't find any news.....